Last 12 months
Inside the activity.
0 purchase rows · 33 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 2 |
| Jan 2026 | 0 | 2 |
| Feb 2026 | 0 | 4 |
| Mar 2026 | 0 | 5 |
| Apr 2026 | 0 | 2 |
| May 2026 | 0 | 3 |
| Jun 2026 | 0 | 3 |
| Jul 2026 | 0 | 3 |
| Aug 2026 | 0 | 5 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 1 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 23, 2025 Filed Feb 25, 2025 23:35 UTC |
Hopkinson Craig C.EVP R&D, Chief Medical Officer
|
Exercise / conversionOrdinary Shares | 7,689 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-006718 · form4.xml · nonDerivative · entry 3 Hopkinson Craig C. · CIK 0001730048 · EVP R&D, Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 77,337 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. Read SEC document |
| February 22, 2025 Filed Feb 25, 2025 23:36 UTC |
Nichols Christian ToddSVP, Chief Commercial Officer
|
Exercise / conversionRestricted Stock Unit Award · Derivative | 7,109 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-006720 · form4.xml · derivative · entry 5 Nichols Christian Todd · CIK 0001813312 · SVP, Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 7,109 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. F2 · derivative.exercise_date: This award is fully vested in accordance with its terms. F2 · derivative.expiration_date: This award is fully vested in accordance with its terms. Read SEC document |
| February 22, 2025 Filed Feb 25, 2025 23:36 UTC |
Nichols Christian ToddSVP, Chief Commercial Officer
|
Tax withholdingOrdinary Shares | 3,157 | $35.32 | $111,505.24 |
DisclosureSEC source: 0001127602-25-006720 · form4.xml · nonDerivative · entry 2 Nichols Christian Todd · CIK 0001813312 · SVP, Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 86,306 Read SEC document |
| February 22, 2025 Filed Feb 25, 2025 23:36 UTC |
Nichols Christian ToddSVP, Chief Commercial Officer
|
Exercise / conversionOrdinary Shares | 7,109 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-006720 · form4.xml · nonDerivative · entry 1 Nichols Christian Todd · CIK 0001813312 · SVP, Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 89,463 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. Read SEC document |
| February 22, 2025 Filed Feb 25, 2025 23:39 UTC |
Gaffin David JosephEVP, CLO, Alkermes, Inc.
|
Exercise / conversionRestricted Stock Unit Award · Derivative | 7,432 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-006724 · form4.xml · derivative · entry 5 Gaffin David Joseph · CIK 0001675905 · EVP, CLO, Alkermes, Inc. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 7,432 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. F2 · derivative.exercise_date: This award is fully vested in accordance with its terms. F2 · derivative.expiration_date: This award is fully vested in accordance with its terms. Read SEC document |
| February 22, 2025 Filed Feb 25, 2025 23:39 UTC |
Gaffin David JosephEVP, CLO, Alkermes, Inc.
|
Tax withholdingOrdinary Shares | 3,300 | $35.32 | $116,556.00 |
DisclosureSEC source: 0001127602-25-006724 · form4.xml · nonDerivative · entry 2 Gaffin David Joseph · CIK 0001675905 · EVP, CLO, Alkermes, Inc. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 196,163 Read SEC document |
| February 22, 2025 Filed Feb 25, 2025 23:39 UTC |
Gaffin David JosephEVP, CLO, Alkermes, Inc.
|
Exercise / conversionOrdinary Shares | 7,432 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-006724 · form4.xml · nonDerivative · entry 1 Gaffin David Joseph · CIK 0001675905 · EVP, CLO, Alkermes, Inc. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 199,463 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. Read SEC document |
| February 22, 2025 Filed Feb 25, 2025 23:39 UTC |
Jackson Blair CurtisEVP, Chief Operating Officer
|
Exercise / conversionRestricted Stock Unit Award · Derivative | 9,694 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-006723 · form4.xml · derivative · entry 5 Jackson Blair Curtis · CIK 0001842348 · EVP, Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 9,694 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. F2 · derivative.exercise_date: This award is fully vested in accordance with its terms. F2 · derivative.expiration_date: This award is fully vested in accordance with its terms. Read SEC document |
| February 22, 2025 Filed Feb 25, 2025 23:39 UTC |
Jackson Blair CurtisEVP, Chief Operating Officer
|
Tax withholdingOrdinary Shares | 4,305 | $35.32 | $152,052.60 |
DisclosureSEC source: 0001127602-25-006723 · form4.xml · nonDerivative · entry 2 Jackson Blair Curtis · CIK 0001842348 · EVP, Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 191,883 Read SEC document |
| February 22, 2025 Filed Feb 25, 2025 23:39 UTC |
Jackson Blair CurtisEVP, Chief Operating Officer
|
Exercise / conversionOrdinary Shares | 9,694 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-006723 · form4.xml · nonDerivative · entry 1 Jackson Blair Curtis · CIK 0001842348 · EVP, Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 196,188 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. Read SEC document |
| February 22, 2025 Filed Feb 25, 2025 23:38 UTC |
Parisi Samuel JosephVP, Finance (Interim PAO)
|
Exercise / conversionRestricted Stock Unit Award · Derivative | 3,114 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-006722 · form4.xml · derivative · entry 6 Parisi Samuel Joseph · CIK 0002010945 · VP, Finance (Interim PAO) 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 3,114 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. F3 · derivative.exercise_date: This award is fully vested in accordance with its terms. F3 · derivative.expiration_date: This award is fully vested in accordance with its terms. Read SEC document |
| February 22, 2025 Filed Feb 25, 2025 23:38 UTC |
Parisi Samuel JosephVP, Finance (Interim PAO)
|
Tax withholdingOrdinary Shares | 983 | $35.32 | $34,719.56 |
DisclosureSEC source: 0001127602-25-006722 · form4.xml · nonDerivative · entry 2 Parisi Samuel Joseph · CIK 0002010945 · VP, Finance (Interim PAO) 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 9,848 Read SEC document |
| February 22, 2025 Filed Feb 25, 2025 23:38 UTC |
Parisi Samuel JosephVP, Finance (Interim PAO)
|
Exercise / conversionOrdinary Shares | 3,114 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-006722 · form4.xml · nonDerivative · entry 1 Parisi Samuel Joseph · CIK 0002010945 · VP, Finance (Interim PAO) 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 10,831 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. Read SEC document |
| February 22, 2025 Filed Feb 25, 2025 23:37 UTC |
Brown Iain MichaelSVP, Chief Financial Officer
|
Exercise / conversionRestricted Stock Unit Award · Derivative | 7,109 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-006721 · form4.xml · derivative · entry 5 Brown Iain Michael · CIK 0001643456 · SVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 7,109 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. F2 · derivative.exercise_date: This award is fully vested in accordance with its terms. F2 · derivative.expiration_date: This award is fully vested in accordance with its terms. Read SEC document |
| February 22, 2025 Filed Feb 25, 2025 23:37 UTC |
Brown Iain MichaelSVP, Chief Financial Officer
|
Tax withholdingOrdinary Shares | 3,154 | $35.32 | $111,399.28 |
DisclosureSEC source: 0001127602-25-006721 · form4.xml · nonDerivative · entry 2 Brown Iain Michael · CIK 0001643456 · SVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 141,835 Read SEC document |
| February 22, 2025 Filed Feb 25, 2025 23:37 UTC |
Brown Iain MichaelSVP, Chief Financial Officer
|
Exercise / conversionOrdinary Shares | 7,109 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-006721 · form4.xml · nonDerivative · entry 1 Brown Iain Michael · CIK 0001643456 · SVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 144,989 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. Read SEC document |
| February 22, 2025 Filed Feb 25, 2025 23:35 UTC |
Hopkinson Craig C.EVP R&D, Chief Medical Officer
|
Exercise / conversionRestricted Stock Unit Award · Derivative | 12,279 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-006718 · form4.xml · derivative · entry 5 Hopkinson Craig C. · CIK 0001730048 · EVP R&D, Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 12,279 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. F2 · derivative.exercise_date: This award is fully vested in accordance with its terms. F2 · derivative.expiration_date: This award is fully vested in accordance with its terms. Read SEC document |
| February 22, 2025 Filed Feb 25, 2025 23:35 UTC |
Hopkinson Craig C.EVP R&D, Chief Medical Officer
|
Tax withholdingOrdinary Shares | 5,452 | $35.32 | $192,564.64 |
DisclosureSEC source: 0001127602-25-006718 · form4.xml · nonDerivative · entry 2 Hopkinson Craig C. · CIK 0001730048 · EVP R&D, Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 69,648 Read SEC document |
| February 22, 2025 Filed Feb 25, 2025 23:35 UTC |
Hopkinson Craig C.EVP R&D, Chief Medical Officer
|
Exercise / conversionOrdinary Shares | 12,279 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-006718 · form4.xml · nonDerivative · entry 1 Hopkinson Craig C. · CIK 0001730048 · EVP R&D, Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,100 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. Read SEC document |
| February 20, 2025 Filed Feb 20, 2025 22:18 UTC |
Parisi Samuel JosephVP, Finance (Interim PAO)
|
SaleOrdinary Shares | 1,327 | $35.69 | $47,360.63 |
DisclosureSEC source: 0001127602-25-006042 · form4.xml · nonDerivative · entry 3 Parisi Samuel Joseph · CIK 0002010945 · VP, Finance (Interim PAO) 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 7,717 F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 9/11/2024. Read SEC document |
| February 19, 2025 Filed Feb 20, 2025 22:11 UTC |
POPS RICHARD FDirector · Director and CEO, Alkermes plc
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 293,921 | $0.00 Strike: $35.84 | $0.00 |
DisclosureSEC source: 0001127602-25-006030 · form4.xml · derivative · entry 1 POPS RICHARD F · CIK 0001126490 · Director · Director and CEO, Alkermes plc 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 293,921 Underlying: Ordinary Shares · 293,921 shares Expires 2035-02-19 F1 · derivative.exercise_date: Shares underlying the stock option vest and become exercisable in four equal annual installments commencing on 2/19/2026. Read SEC document |
| February 19, 2025 Filed Feb 20, 2025 22:17 UTC |
Nichols Christian ToddSVP, Chief Commercial Officer
|
GrantRestricted Stock Unit Award · Derivative | 24,182 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-006040 · form4.xml · derivative · entry 5 Nichols Christian Todd · CIK 0001813312 · SVP, Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,182 Underlying: Ordinary Shares · 24,182 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share. F4 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/19/2026. F4 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/19/2026. Read SEC document |
| February 19, 2025 Filed Feb 20, 2025 22:17 UTC |
Nichols Christian ToddSVP, Chief Commercial Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 50,417 | $0.00 Strike: $35.84 | $0.00 |
DisclosureSEC source: 0001127602-25-006040 · form4.xml · derivative · entry 4 Nichols Christian Todd · CIK 0001813312 · SVP, Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,417 Underlying: Ordinary Shares · 50,417 shares Expires 2035-02-19 F3 · derivative.exercise_date: Shares underlying the stock option vest and become exercisable in four equal annual installments commencing on 2/19/2026. Read SEC document |
| February 19, 2025 Filed Feb 20, 2025 22:18 UTC |
Parisi Samuel JosephVP, Finance (Interim PAO)
|
GrantRestricted Stock Unit Award · Derivative | 11,965 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-006042 · form4.xml · derivative · entry 6 Parisi Samuel Joseph · CIK 0002010945 · VP, Finance (Interim PAO) 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 11,965 Underlying: Ordinary Shares · 11,965 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share. F5 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/19/2026. F5 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/19/2026. Read SEC document |
| February 19, 2025 Filed Feb 20, 2025 22:18 UTC |
Parisi Samuel JosephVP, Finance (Interim PAO)
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 12,287 | $0.00 Strike: $35.84 | $0.00 |
DisclosureSEC source: 0001127602-25-006042 · form4.xml · derivative · entry 5 Parisi Samuel Joseph · CIK 0002010945 · VP, Finance (Interim PAO) 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 12,287 Underlying: Ordinary Shares · 12,287 shares Expires 2035-02-19 F4 · derivative.exercise_date: Shares underlying the stock option vest and become exercisable in four equal annual installments commencing on 2/19/2026. Read SEC document |
| February 19, 2025 Filed Feb 20, 2025 22:16 UTC |
Gaffin David JosephEVP, CLO, Alkermes, Inc.
|
GrantRestricted Stock Unit Award · Derivative | 30,692 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-006038 · form4.xml · derivative · entry 5 Gaffin David Joseph · CIK 0001675905 · EVP, CLO, Alkermes, Inc. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,692 Underlying: Ordinary Shares · 30,692 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share. F4 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/19/2026. F4 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/19/2026. Read SEC document |
| February 19, 2025 Filed Feb 20, 2025 22:16 UTC |
Gaffin David JosephEVP, CLO, Alkermes, Inc.
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 63,991 | $0.00 Strike: $35.84 | $0.00 |
DisclosureSEC source: 0001127602-25-006038 · form4.xml · derivative · entry 4 Gaffin David Joseph · CIK 0001675905 · EVP, CLO, Alkermes, Inc. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63,991 Underlying: Ordinary Shares · 63,991 shares Expires 2035-02-19 F3 · derivative.exercise_date: Shares underlying the stock option vest and become exercisable in four equal annual installments commencing on 2/19/2026. Read SEC document |
| February 19, 2025 Filed Feb 20, 2025 22:14 UTC |
Jackson Blair CurtisEVP, Chief Operating Officer
|
GrantRestricted Stock Unit Award · Derivative | 37,203 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-006035 · form4.xml · derivative · entry 5 Jackson Blair Curtis · CIK 0001842348 · EVP, Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,203 Underlying: Ordinary Shares · 37,203 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share. F4 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/19/2026. F4 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/19/2026. Read SEC document |
| February 19, 2025 Filed Feb 20, 2025 22:14 UTC |
Jackson Blair CurtisEVP, Chief Operating Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 77,565 | $0.00 Strike: $35.84 | $0.00 |
DisclosureSEC source: 0001127602-25-006035 · form4.xml · derivative · entry 4 Jackson Blair Curtis · CIK 0001842348 · EVP, Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 77,565 Underlying: Ordinary Shares · 77,565 shares Expires 2035-02-19 F3 · derivative.exercise_date: Shares underlying the stock option vest and become exercisable in four equal annual installments commencing on 2/19/2026. Read SEC document |
| February 19, 2025 Filed Feb 20, 2025 22:13 UTC |
Hopkinson Craig C.EVP R&D, Chief Medical Officer
|
GrantRestricted Stock Unit Award · Derivative | 30,692 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-006033 · form4.xml · derivative · entry 5 Hopkinson Craig C. · CIK 0001730048 · EVP R&D, Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,692 Underlying: Ordinary Shares · 30,692 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share. F4 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/19/2026. F4 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/19/2026. Read SEC document |
| February 19, 2025 Filed Feb 20, 2025 22:13 UTC |
Hopkinson Craig C.EVP R&D, Chief Medical Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 63,991 | $0.00 Strike: $35.84 | $0.00 |
DisclosureSEC source: 0001127602-25-006033 · form4.xml · derivative · entry 4 Hopkinson Craig C. · CIK 0001730048 · EVP R&D, Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63,991 Underlying: Ordinary Shares · 63,991 shares Expires 2035-02-19 F3 · derivative.exercise_date: Shares underlying the stock option vest and become exercisable in four equal annual installments commencing on 2/19/2026. Read SEC document |
| February 18, 2025 Filed Feb 20, 2025 22:17 UTC |
Nichols Christian ToddSVP, Chief Commercial Officer
|
Exercise / conversionRestricted Stock Unit Award · Derivative | 6,354 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-006040 · form4.xml · derivative · entry 3 Nichols Christian Todd · CIK 0001813312 · SVP, Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,355 Underlying: Ordinary Shares · 6,354 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. F2 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/18/2023. F2 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/18/2023. Read SEC document |
| February 18, 2025 Filed Feb 20, 2025 22:17 UTC |
Nichols Christian ToddSVP, Chief Commercial Officer
|
Tax withholdingOrdinary Shares | 1,869 | $35.90 | $67,097.10 |
DisclosureSEC source: 0001127602-25-006040 · form4.xml · nonDerivative · entry 2 Nichols Christian Todd · CIK 0001813312 · SVP, Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 82,354 Read SEC document |
| February 18, 2025 Filed Feb 20, 2025 22:17 UTC |
Nichols Christian ToddSVP, Chief Commercial Officer
|
Exercise / conversionOrdinary Shares | 6,354 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-006040 · form4.xml · nonDerivative · entry 1 Nichols Christian Todd · CIK 0001813312 · SVP, Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 84,223 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. Read SEC document |
| February 18, 2025 Filed Feb 20, 2025 22:18 UTC |
Parisi Samuel JosephVP, Finance (Interim PAO)
|
Exercise / conversionRestricted Stock Unit Award · Derivative | 2,033 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-006042 · form4.xml · derivative · entry 4 Parisi Samuel Joseph · CIK 0002010945 · VP, Finance (Interim PAO) 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,034 Underlying: Ordinary Shares · 2,033 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. F3 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/18/2023. F3 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/18/2023. Read SEC document |
| February 18, 2025 Filed Feb 20, 2025 22:18 UTC |
Parisi Samuel JosephVP, Finance (Interim PAO)
|
Tax withholdingOrdinary Shares | 706 | $35.90 | $25,345.40 |
DisclosureSEC source: 0001127602-25-006042 · form4.xml · nonDerivative · entry 2 Parisi Samuel Joseph · CIK 0002010945 · VP, Finance (Interim PAO) 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 9,044 Read SEC document |
| February 18, 2025 Filed Feb 20, 2025 22:18 UTC |
Parisi Samuel JosephVP, Finance (Interim PAO)
|
Exercise / conversionOrdinary Shares | 2,033 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-006042 · form4.xml · nonDerivative · entry 1 Parisi Samuel Joseph · CIK 0002010945 · VP, Finance (Interim PAO) 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 9,750 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. Read SEC document |
| February 18, 2025 Filed Feb 20, 2025 22:16 UTC |
Gaffin David JosephEVP, CLO, Alkermes, Inc.
|
Exercise / conversionRestricted Stock Unit Award · Derivative | 6,354 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-006038 · form4.xml · derivative · entry 3 Gaffin David Joseph · CIK 0001675905 · EVP, CLO, Alkermes, Inc. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,355 Underlying: Ordinary Shares · 6,354 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. F2 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/18/2023. F2 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/18/2023. Read SEC document |
| February 18, 2025 Filed Feb 20, 2025 22:16 UTC |
Gaffin David JosephEVP, CLO, Alkermes, Inc.
|
Tax withholdingOrdinary Shares | 2,822 | $35.90 | $101,309.80 |
DisclosureSEC source: 0001127602-25-006038 · form4.xml · nonDerivative · entry 2 Gaffin David Joseph · CIK 0001675905 · EVP, CLO, Alkermes, Inc. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 192,031 Read SEC document |
| February 18, 2025 Filed Feb 20, 2025 22:16 UTC |
Gaffin David JosephEVP, CLO, Alkermes, Inc.
|
Exercise / conversionOrdinary Shares | 6,354 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-006038 · form4.xml · nonDerivative · entry 1 Gaffin David Joseph · CIK 0001675905 · EVP, CLO, Alkermes, Inc. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 194,853 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. Read SEC document |
| February 18, 2025 Filed Feb 20, 2025 22:15 UTC |
Brown Iain MichaelSVP, Chief Financial Officer
|
Exercise / conversionRestricted Stock Unit Award · Derivative | 6,354 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-006037 · form4.xml · derivative · entry 3 Brown Iain Michael · CIK 0001643456 · SVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,355 Underlying: Ordinary Shares · 6,354 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. F2 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/18/2023. F2 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/18/2023. Read SEC document |
| February 18, 2025 Filed Feb 20, 2025 22:15 UTC |
Brown Iain MichaelSVP, Chief Financial Officer
|
Tax withholdingOrdinary Shares | 1,869 | $35.90 | $67,097.10 |
DisclosureSEC source: 0001127602-25-006037 · form4.xml · nonDerivative · entry 2 Brown Iain Michael · CIK 0001643456 · SVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 137,880 Read SEC document |
| February 18, 2025 Filed Feb 20, 2025 22:15 UTC |
Brown Iain MichaelSVP, Chief Financial Officer
|
Exercise / conversionOrdinary Shares | 6,354 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-006037 · form4.xml · nonDerivative · entry 1 Brown Iain Michael · CIK 0001643456 · SVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 139,749 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. Read SEC document |
| February 18, 2025 Filed Feb 20, 2025 22:14 UTC |
Jackson Blair CurtisEVP, Chief Operating Officer
|
Exercise / conversionRestricted Stock Unit Award · Derivative | 8,896 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-006035 · form4.xml · derivative · entry 3 Jackson Blair Curtis · CIK 0001842348 · EVP, Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,897 Underlying: Ordinary Shares · 8,896 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. F2 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/18/2023. F2 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/18/2023. Read SEC document |
| February 18, 2025 Filed Feb 20, 2025 22:14 UTC |
Jackson Blair CurtisEVP, Chief Operating Officer
|
Tax withholdingOrdinary Shares | 3,950 | $35.90 | $141,805.00 |
DisclosureSEC source: 0001127602-25-006035 · form4.xml · nonDerivative · entry 2 Jackson Blair Curtis · CIK 0001842348 · EVP, Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 186,494 Read SEC document |
| February 18, 2025 Filed Feb 20, 2025 22:14 UTC |
Jackson Blair CurtisEVP, Chief Operating Officer
|
Exercise / conversionOrdinary Shares | 8,896 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-006035 · form4.xml · nonDerivative · entry 1 Jackson Blair Curtis · CIK 0001842348 · EVP, Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 190,444 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. Read SEC document |
| February 18, 2025 Filed Feb 20, 2025 22:13 UTC |
Hopkinson Craig C.EVP R&D, Chief Medical Officer
|
Exercise / conversionRestricted Stock Unit Award · Derivative | 8,896 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-006033 · form4.xml · derivative · entry 3 Hopkinson Craig C. · CIK 0001730048 · EVP R&D, Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,897 Underlying: Ordinary Shares · 8,896 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. F2 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/18/2023. F2 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/18/2023. Read SEC document |
| February 18, 2025 Filed Feb 20, 2025 22:13 UTC |
Hopkinson Craig C.EVP R&D, Chief Medical Officer
|
Tax withholdingOrdinary Shares | 3,950 | $35.90 | $141,805.00 |
DisclosureSEC source: 0001127602-25-006033 · form4.xml · nonDerivative · entry 2 Hopkinson Craig C. · CIK 0001730048 · EVP R&D, Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,821 Read SEC document |
| February 18, 2025 Filed Feb 20, 2025 22:13 UTC |
Hopkinson Craig C.EVP R&D, Chief Medical Officer
|
Exercise / conversionOrdinary Shares | 8,896 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-006033 · form4.xml · nonDerivative · entry 1 Hopkinson Craig C. · CIK 0001730048 · EVP R&D, Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,771 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. Read SEC document |
| February 13, 2025 Filed Feb 14, 2025 22:12 UTC |
Hopkinson Craig C.EVP R&D, Chief Medical Officer
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 35,586 | $0.00 Strike: $24.59 | $0.00 |
DisclosureSEC source: 0001127602-25-004948 · form4.xml · derivative · entry 12 Hopkinson Craig C. · CIK 0001730048 · EVP R&D, Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 71,172 Underlying: Ordinary Shares · 35,586 shares Expires 2032-02-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 12/14/2023. F9 · derivative.exercise_date: Shares underlying the stock option vest and become exercisable in four equal annual installments commencing on 2/18/2023. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.